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Abstract
Background: The present study was designed to evaluate which arterial stiffness parameter - AASI or the home
arterial stiffness index (HASI) - correlates best with vascular, cardiac and renal damage in hypertensive individuals.
Methods: A cross-sectional study was carried out involving 258 hypertensive patients. AASI and HASI were defined
as the 1-regression slope of diastolic over systolic blood pressure readings obtained from 24-hour recordings and
home blood pressure over 6 days. Renal damage was evaluated by glomerular filtration rate (GFR) and
microalbuminuria; vascular damage by carotid intima-media thickness (IMT), pulse wave velocity (PWV) and ankle/
brachial index (ABI); and left ventricular hypertrophy by the Cornell voltage-duration product (VDP) and the
Novacode index.
Results: AASI and HASI were not correlated with microalbuminuria, however AASI and HASI- blood pressure
variability ratio (BPVR) showed negative correlation with GRF. The Cornell PDV was positively correlated with AASI-
BPVR-Sleep (r = 0.15, p < 0.05) and the left ventricular mass index with HASI-BPVR (r = 0.19, p < 0.01). Carotid IMT
and PWV were positively correlated with all the parameters except the HASI, while ABI was negatively correlated
with AASI and Awake-AASI. After adjusting for age, gender and 24 hours heart rate, statistical significance remains
of the IMT with AASI, Awake AASI and AASI-BPVR. PWV with the AASI, Awake-AASI and Sleep-AASI. ABI with AASI
and Awake-AASI. Odd Ratio to presence target organ damage was for AASI: 10.47(IC95% 1.29 to 65.34), Awake-
AASI: 8.85(IC95% 1.10 to 71.04), Sleep-AASI: 2.19(IC95% 1.10 to 4.38) and AASI-BPVR-night: 4.09 (IC95% 1.12 to
14.92).
Conclusions: After adjusting for age, gender and 24-hour heart, the variables that best associated with the
variability of IMT, PWV and ABI were AASI and Awake-AASI, and with GFR was HASI-BPVR.
Keywords: Ambulatory arterial stiffness index, home arterial stiffness index, ambulatory blood pressure monitoring,
home blood pressure, target organ damage
1.- Background
The ambulatory arterial stiffness index (AASI) is related
to cardiovascular morbidity-mortality [1,2] and to the
presence of associated target organ damage (TOD) in
hypertensive patients [3-8]. The AASI is very useful for
assessing arterial stiffness, shows a strong correlation to
other classical measures such as pulse wave velocity
(PWV) [9,10], and in contrast to the latter requires no
special or costly equipment. However, AASI determina-
tion requires ambulatory blood pressure monitoring
(ABPM), which limits its generalized use in clinical
practice.
Taking into account the above, home blood pressure
monitoring (HBP) also offers a range of measures of
blood pressure in the usual environment of the indivi-
dual, with a good correlation to cardiovascular morbid-
ity-mortality [11] and thep r e s e n c eo fT O D[ 3 , 6 , 7 ] ;
moreover, its use is less costly and more accessible, and
the technique is better accepted by the patients.
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index (HASI) and AASI has not been well established. A
study has concluded that HASI may serve as a useful
surrogate measure of arterial stiffness [12], while other
authors consider HASI to be less closely associated to
markers of arterial stiffness [13,14]. We were interested
in determining whether the arterial stiffness index calcu-
lated by HASI may be an alternative to AASI in predict-
ing TOD. If the measurements of the two parameters
are similar, then HASI would have a considerable poten-
tial for application in clinical practice. If not found to be
similar, we can determine whether AASI and HASI are
correlated differently with other vascular, cardiac or
renal lesions, and whether they can have different impli-
cations in clinical practice.
The present study was designed to evaluate which
arterial stiffness parameter - AASI or the home arterial
stiffness index (HASI) - correlates best with vascular,
cardiac and renal damage in hypertensive individuals.
2.- Methods
2.1.- Study design and population
A cross-sectional study was carried out in a primary
care setting. We consecutively included all hypertensive
subjects visiting primary care clinics between January
2008 and January 2011, and referred to the research
unit for the assessment of cardiovascular risk. Hyperten-
sion was diagnosed when the mean of three recordings
in the clinic under basal conditions and separated in
time revealed systolic blood pressure (SBP) ≥ 140 and/
or diastolic blood pressure (DBP) ≥ 90 mmHg. On each
visit at least two recordings were made, spaced more
than one minute apart. The included patients were aged
30-80 years, and individuals with a history of cardiovas-
cular disease (ischemic heart disease or stroke) or dia-
betes mellitus were excluded. The sample size to detect
a minimum correlation coefficient of 0.2 with two-sided
type I error rate of 5% and 80% power was estimated to
be 194 individuals The sample of 258 subjects was
therefore considered to be sufficient for this study,
which adhered to the principles of the Declaration of
Helsinki, and was approved by an independent ethics
committee of Salamanca University Hospital (Spain).
Written informed consent to participation in the study
was obtained in all cases.
2.2.- Measurement
2.2.1.- Office or clinical blood pressure
Office blood pressure measurement involves three mea-
surements of SBP and DBP, using the average of the last
two measurements, with a validated OMRON model
M7 sphygmomanometer (Omron Health Care, Kyoto,
Japan), and following the recommendations of the Eur-
opean Society of Hypertension [15]. The office blood
pressure values used in the study were the mean values
of the last two measurements.
2.2.2.- Home blood pressure (HBP)
Three measurements were made in the morning
(between 6:00 and 9:00 a.m.), and three in the after-
noon/evening (between 18:00 and 21:00 p.m.), over a
period of 7 days, with a minimum interval of one min-
ute between measurements, and excluding the first mea-
surement and the values corresponding to the first day
of measurement [16]. Twenty-four blood pressure mea-
surements were used to estimate HASI. The same
sphygmomanometer model used to measure blood pres-
sure in the office was employed. Each patient included
in the study received an instructions sheet and a form
specifically designed for recording the blood pressure
values.
2.2.3.- Ambulatory blood pressure monitoring (ABPM)
ABPM was performed on a day of standard activity, with
an adequate cuff for the size of the patient’s arm. A con-
trol system (Spacelabs 90207, Healthcare, Issaquah,
Washington, USA), validated according to the protocol
of the British Hypertension Society, was used [17]. The
records of readings considered to be valid were ≥ 80%
of the total. The monitor was programmed for obtaining
blood pressure measurements every 20 min during the
waking period and every 30 min during the resting per-
iod. Individual correction was made of the waking and
sleeping hours reported by the patient.
2.2.4.- Assessment of carotid intima-media thickness (IMT)
Carotid ultrasonography to assess IMT was performed by
two investigators trained for this purpose before starting
the study. A Sonosite Micromax ultrasound device paired
with a 5-10 MHz multifrequency high-resolution linear
transducer with Sonocal software was used for perform-
ing automatic measurements of IMT, in order to opti-
mize reproducibility. Measurements were made of the
common carotid artery after the examination of a longi-
tudinal section of 10 mm at a distance of 1 cm from the
bifurcation, performing measurements in the proximal
wall, and in the distal wall in the lateral, anterior and pos-
terior projections, following an axis perpendicular to the
artery to discriminate two lines (one for the intima-blood
interface and the other for the media-adventitia inter-
face). A total of 6 measurements were obtained of the
right carotid and another 6 of the left carotid. The mea-
surements were obtained, following the recommenda-
tions of the Manheim Carotid Intima-Media Thickness
Consensus [18]. The average IMT was considered abnor-
mal if it measured 0.90 mm, or if there were athero-
sclerotic plaques with a diameter of 1.5 mm or a focal
increase of 0.5 mm or 50% of the adjacent IMT [19].
2.2.5.- Evaluation of peripheral artery involvement
This was evaluated using the ankle/brachial index (ABI).
The blood pressure in the upper and lower extremities
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Es-100Vx (Hadeco, Inc. Arima, Miyamae-ku, Kawasaki,
Japan), applying the probe at the posterior tibial artery
at an angle of approximately 60° to the direction of
blood flow
The ABI was calculated separately for each foot by
dividing the higher of the two systolic pressures in the
ankle by the higher of the two systolic pressures in the
arm. TOD was considered if the ABI was lower than 0.9
[19].
2.2.6.- Pulse wave velocity (PWV)
P u l s ew a v ev e l o c i t y( P W V )was estimated with the
SphygmoCor System (AtCor Medical Pty Ltd Head
Office, West Ryde, Australia), with the patient in the
supine position. The pulse waves of the carotid and
femoral arteries were analyzed, estimating the delay with
respect to the ECG wave and calculating PWV. PWV is
calculed as the ratio of the distance travelled (calculated
as distance in mm of distal minus proximal, where mea-
sures are taken from the suprasternal notch to the sam-
pling site) and the foot-to-foot time delay between the
pulse waves and expressed in meters per second (m/
sec). TOD was considered if the PWV was higher than
12 m/sec [19].
2.2.7.- Renal assessment
Kidney damage was assessed by measuring creatinine
plasma concentration; the glomerular filtration rate
(GFR) was estimated by the CKD-EPI (Chronic Kidney
Disease Epidemiology Collaboration) for Caucasians
[20]; and proteinuria was determined from the albumin/
creatinine ratio following the ESH 2007 criteria. TOD
was defined as plasma creatinine 1.3 mg/100 ml or
higher in men and 1.2 mg/100 ml or higher in women,
and GFR below 60 ml/min or an albumin/creatinine
ratio ≥ 22 mg/g in men and ≥ 31 mg/g in women [19].
2.2.8.- Cardiac assessment
The electrocardiographic examination was performed
using a General Electric MAC 3.500 ECG System (Gen-
eral Electric, Niskayuna, NY, USA) that automatically
measures the voltage and duration of waves and esti-
mates the criteria of the Cornell voltage duration pro-
duct (Cornell-VDP) [21]. The left ventricular mass index
(LVMI) was estimated by the Novacode equation
[19,22]. TOD was defined According to the 2007 Eur-
opean Society of Hypertension/European Society of Car-
diology Guidelines criteria [19].
2.2.9.- AASI and HASI
Arterial stiffness was evaluate with ambulatory arterial
stiffness index (AASI and AASI- blood pressure variabil-
ity (BPVR)) and home arterial stiffness index (HASI and
HASI (BPVR)). For AASI and HASI estimation, the
regression slope of diastolic on systolic blood pressure
was computed for each individual on the basis of 24-
hour ABPM (AASI) and also HBP readings (HASI) over
6 days. AASI as well as HASI were defined as one
minus the respective regression slope of DBP on SBP.
AASI was also computed from waking or sleeping blood
pressure. Blood pressure variability ratio (BPVR) was
defined as SD (SBP)/SD(DBP), AASI (BPVR) as 1-[1/SD
(SBP)/SD (DBP)] in 24-hour blood pressure [23-25], and
HASI (BPVR) as 1-[1/SD (SBP)/SD (DBP)] over 6 days
of HBP recording.
The individuals performing the different tests were
blinded to the clinical data of the patient. All organ
damage assessment measures were made within a period
of 10 days.
2.3.- Statistical analysis
Continuous variables were expressed as the mean ±
standard deviation (SD), while frequency distributions
were used for qualitative variables. Mean of AASI and
HASI were adjusted by age and gender based on analy-
sis of covariance (ANCOVA). Pearson’s correlation coef-
ficient was used to estimate the relationship between
quantitative variables, while the chi-squared test was
used to associate qualitative variables. We performed
multiple linear regression analysis using carotid IMT,
PWV, ABI, Cornell PDV and glomerular filtration as
dependent variables. The enter method was used in a
first step to include as adjustment variables patient age,
gender (male = 1; female = 0) and 24-hour heart rate,
and then we included one by one the independent vari-
ables (AASI, Awake-AASI, Sleep-AASI, AASI-BPVR,
AASI-BPVR-Awake, AASI-BPVR-Sleep HASI and
HASI-BPVR) to avoid collinearity. Logistic regression
analysis by the enter method was performed to evaluate
the association between ambulatory arterial stiffness
measures as independent variables, included one by one,
and TOD as the dependent variable (1 with TOD and 0
without TOD), adjusted by age and gender. The data
were analyzed using the SPSS version 18.0 statistical
package (SPSS Inc., Chicago, Illinois, USA).
3.- Results
The demographic and clinical characteristics, office and
ambulatory blood pressure parameters used to evaluate
TOD, and the arterial stiffness indices are reported in
Tables 1 and 2. The mean age was 53 years, and 60% of
the patients were males. The mean 24-hour and Awake-
AASI was 0.37 ± 0.06, Sleep-AASI was 0.38 ± 0.15, and
HASI was 0.59 ± 0.18. Fourteen percent of the hyper-
tensive patients showed renal damage, 21% vascular
damage, and 9% left ventricular hypertrophy (LVH).
Table 3 shows the correlation between ambulatory
arterial stiffness measures and target organ damage
indices. Age was positively correlated with all the ambu-
latory arterial stiffness measures, being the lowest with
HASI (r = 0.13, p < 0.05) and the highest with AASI-
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correlation with PP than HASI.. AASI and HASI not
correlated with microalbuminuria and AASI and HASI-
BPVR proved negative to CKD-EPI. The Cornell PDV
was positively correlated with AASI-BPVR-Sleep (r =
0.15, p < 0.05), and LVMI with HASI-BPVR (r = 0.19, p
< 0.01). Carotid IMT and PWV were positively corre-
lated with all the parameters except HASI, while ABI
was negatively correlated with AASI and Awake-AASI.
The correlation of PWV with office PP was: (r = 0.32,
p < 0.01); with PP ABPM 24 h (r = 0.33, p < 0.01); and
with PP HOME BP (r = 0.39, p < 0.01).
The observed correlations between AASI with TOD
indices were greater (p < 0.05) than those of HASI in
GFR, carotid IMT, PWV and ABI. The results were not
Table 1 General demographic and clinics characteristics
in hypertensive patients.
Variables N = 258
Age 53.3 ± 2.0
Male, n (%) 153(59.3)
Smokers, n (%) 64(24.8)
Body mass index, kg/m2 27.92 ± 3.83
Waist circumference, (cm) 95.60 ± 11.12
Total Cholesterol, (mg/dl) 208.96 ± 36.94
Tryglicerides, (mg/dl) 126.34 ± 73.35
LDL cholesterol, (mg/dl) 130.64 ± 33.00
HDL cholesterol,(mg/dl) 53.28 ± 3.01
Serum creatinine, (mg/dl) 0.90 ± 0.19
Albumin/creatinine (mgg) 14.65 ± 48.59
GFR estimated with CKD-EPI 88.62 ± 15.41
Cornell VDP (mmms) 1543.89 ± 695.93
LVMI (gm
2) Novocode 74.85 ± 18.33
Carotid IMT (mm) 0.71 ± 0.12
PWV (m/sec) 8.65 ± 2.06
ABI 1.08 ± 0.10
AASI 0.37 ± 0.06
Awake-AASI 0.37 ± 0.06
Sleep-AASI 0.38 ± 0.15
AASI-BPVR 0.16 ± 0.16
AASI-BPVR-Awake 0.19 ± 0.20
AASI-BPVR-Sleep 0.08 ± 0.25
HASI 0.59 ± 0.18





Data for qualitative variables are expressed as n (%) and quantitative variables
as mean ± standard deviation. LDL: Low density lipoprotein; HDL: High
density lipoprotein; GFR: Glomerular filtration; CKD-EPI: Chronic Kidney Disease
Epidemiology Collaboration; VDP: Voltage-duration product; LVMI: Left
ventricular mass index; IMT: Intima-media thickness; ABI: Ankle/brachial index;
PWV: Pulse wave velocity; AASI: Ambulatory arterial stiffness index; Awake
AASI = Ambulatory arterial stiffness index in Awake time; Sleep AASI:
Ambulatory arterial stiffness index in sleep time; BPVR: Blood pressure
variability ratio; HASI: Home arterial stiffness index; TOD: target organ damage.
Table 2 Characteristics of blood pressure assessed by
different methods and used antihypertensive drugs.
Variables
Years of evolution of hypertension 7.0 ± 5.5
Subjects receiving drug treatment n(%) 101(39.1)
Patients with white coat hypertension n(%) 32(20.4)
Drugs used in treatment
Diuretics n(%) 44(17.1)
ACE inhibitors n(%) 37(14.3)
Angiotensin receptor blockers n (%) 33(12.8)
Calcium channel blockers n (%) 16(6.2)
Office BP (mmHg)
SBP, mm Hg 139.9 ± 16.8
DBP, mm Hg 88.3 ± 10.7
PP, mm Hg 52.2 ± 12.8
HR bpm 72.1 ± 12.9
ABPM 24 hours (mmHg)
SBP, mm Hg 126.7 ± 12.8
DBP, mm Hg 78.7 ± 9.9
PP, mm Hg 47.9 ± 9.5
HR bpm 71.9 ± 10.6
SD SBP 13.8 ± 3.3
SD DBP 11.3 ± 2.4
N° blood pressure measurement 60
Awake time ABMP (mmHg)
SBP, mm Hg 130.6 ± 13.3
DBP, mm Hg 82.3 ± 10.6
PP, mm Hg 48.4 ± 9.5
HR bpm 75.1 ± 11.6
SD SBP 11.9 ± 3.3
SD DBP 9.5 ± 2.5
N° blood pressure measurement 45
Sleep time ABPM (mmHg)
SBP, mm Hg 115.1 ± 14.5
DBP, mm Hg 68.3 ± 9.9
PP, mm Hg 46.9 ± 10.2
HR bpm 62.6 ± 9.2
SD SBP 10.3 ± 3.5
SD DBP 9.1 ± 2.8
N° blood pressure measurement 15
Sleep/Awake ratio SBP 0.9 ± 0.1
Sleep/Awake ratio DBP 0.8 ± 0.1
% Dipping Systolic 11.7 ± 8.0
HOME BP (mmHg)
SBP, mm Hg 127.2 ± 14.4
DBP, mm Hg 81.6 ± 9.8
PP, mm Hg 45.6 ± 10.1
HR bpm 68.4 ± 9.1
SD SBP 9.1 ± 3.4
SD DBP 6.2 ± 2.3
N° blood pressure measurement 28
Data for qualitative variables are expressed as n (%) and quantitative variables
as mean ± standard deviation.
ACE: angiotensin-converting enzyme; SBP: systolic blood pressure; DBP:
dyastolic blood pressure; PP: pulse pressure; HR: heart rate; bpm: beats per
minute; ABPM: ambulatory blood pressure monitoring; BP: blood pressure.
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with white coat hypertension, or on separately analyzing
those receiving drug treatment and those receiving no
drug treatment.
After adjusting for age, gender and 24 hours heart rate
(table 4), statistical significance remains of the IMT with
AASI (b = 0.32), Awake-AASI (b = 0.29) and AASI-
BPVR (b =0 . 0 8 .P W Vw i t ht h eA A S I( b =4 . 9 5 ) ,
Awake-AASI (b = 4.57) and Sleep-AASI (b = 2.47). ABI
with AASI (b = -0.28) and Awake-AASI (b = -0.28).
Finally CKDEPI only with HASI-BPVR (b = -7.35) and
with heart indices no ambulatory arterial stiffness mea-
sures reached statistical significance.
Figure 1 shows the boxplots for AASI and HASI
according to the presence or absence of renal, vascular
or cardiac damage. Mean of AASI and HASI were
adjusted by for age and gender. The Odds ratio (OR) of
ambulatory arterial stiffness measures, adjusted by age,
gender and 24 hours heart rate, to predict TOD, were
for AASI: 1.83 (IC95% 1.07 to 3.22), Awake-AASI: 1.78
(IC95% 1.08 to 3.08), Sleep-AASI: 1.17 (IC95% 0.47 to
3.07) and AASI-BPVR-Sleep: 1.15 (IC95% 1.01 to 1.31).
Else measures did not reached statistical significance.
According to the Bland-Altman analysis the limits of
intra-observer agreement was 0.13 (95%CI:-0.36 to 0.61)
and the repeatability coefficients was 0.49 (Figure 2).
4.- Discussion
The present study shows that the behavior of the two
approaches for measuring stiffness through home blood
pressure monitoring and its relation to TOD differs.
Thus, while HASI is not correlated to any of the para-
meters used to evaluate the presence of TOD in hyper-
tensive patients, HASI-BPVR is positively correlated
with IMT and PWV, and shows a negative correlation
with GFR, in the same way as the AASI indices except
Sleep-AASI, which shows a negative correlation with
GFR. In turn, AASI-BPVR-Sleep and which shows a
positively correlation with Cornell-PDV and HASI-
BPVR which shows a positively correlation with LVMI.
These results indicate that stiffness arterial assessed
with HASI-BPVR to detect the presence of vascular,
renal or cardiac damage associated to hypertensive
patients is better than HASI.
In previous studies, Qureshi et al. [12] reported mean
HASI scores of 0.62 ± 0.20 in 49 hypertensive patients.
Stergiou GS et al.[13], in a series of 483 treated and
non-treated hypertensive subjects, reported a mean
HASI score of 0.66 ± 0.17 the latter being higher than
the corresponding 24-hour AASI score (0.33 ± 0.15),
Awake-AASI (0.50 ± 0.18) and Sleep-AASI (0.37 ±
0.19). These results are similar to the HASI findings in
our own series (0.59 ± 0.18), and differ from our 24-
hour AASI score (0.37 ± 0.06) and Awake-AASI (0.37 ±
0.06) and Sleep-AASI scores (0.38 ± 0.15), which yielded
similar values.
The correlations found between HASI and the AASI
measures have an r-value of close to 0.18, while the
values reported by Stergiou [13] were r = 0.14 for 24-
hour and Awake-AASI, and r = 0.09 for Sleep-AASI. In
the same way as published by other authors [12,13],
positive associations are observed between AASI and
HASI and patient age and pulse pressure in its different
measures.
The positive association between AASI and TOD has
already been reported by Leoncini et at. [4] in 188 sub-
jects without drug treatment the risk of developing any
form of TOD being found to be greater as the AASI
Table 3 Bivariate correlations of AASI and HASI with age and target organ damage in hypertensive patients
AASI 24 h Awake-AASI Sleep-AASI AASI-BPVR HASI HASI-BPVR
Age 0.42** 0.41** 0.18** 0.44** 0.13* 0.32**
Office PP, mm Hg 0.58** 0.57** 0.25** 0.42** 0.13* 0.15*
ABPM 24 h PP, mm Hg 0.85** 0.85** 0.38** 0.46** 0.21** 0.12
HOME BP PP, mm Hg 0.61** 0.60** 0.28** 0.39** 0.18** 0.16**
CKD-EPI -0.31** -0.30** -0.12 -0.26** -0.06 -0.27**
Albumin/creatinine (mgg) 0.11 0.11 -0.01 0.08 -0.02 0.05
Cornell VDP (mmms) 0.03 0.01 0.02 0.09 -0.01 0.01
LVMI (gm
2) Novocode 0.03 0.02 0.05 0.07 0.05 0.19**
Carotid IMT (mm) 0.41** 0.39** 0.19** 0.38** 0.07 0.22**
PWV (m/seg) 0.29** 0.28** 0.25** 0.29** 0.05 0.24**
ABI -0.13* -0.13* -0.04 -0.01 0.03 -0.01
AASI: Ambulatory arterial stiffness index; HASI: Home arterial stiffness index; H: Hours; Awake AASI: Ambulatory arterial -stiffness index in Awake time; Sleep-AASI:
Ambulatory arterial stiffness index in sleep time; BPVR: Blood pressure variability ratio; PP: pulse pressure; ABPM: Ambulatory blood pressure monitoring; BP:
Blood pressure; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; VDP: Voltage-duration product; LVMI: Left ventricular mass index; IMT: Intima-media
thickness; PWV: Pulse wave velocity; ABI: Ankle/brachial index; AASI: Ambulatory arterial stiffness index.
*p < 0.05, statistically differences, **p < 0.01, statistically differences.
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study of 554 hypertensive individuals with and without
treatment, reported correlations between AASI and
TOD similar to those found in our series. Our results
showed a higher AASI score in the case of subjects
with renal and vascular damage. The association
between left ventricular hypertrophy and AASI is not
clear. Schillaci et al. [27] reported a relationship
between AASI and the left ventricular mass index,
assessing the latter by means of echocardiography in
non-treated hypertensive individuals. However, in coin-
cidence with the observations of Leoncini et al [4], the
association lost strength upon adjusting for age and
gender. In our study, AASI was not related to the elec-
trocardiographic parameters used to assess LVMI.
However, we found a positive correlation between
HASI (BPVR) and LVMI estimated with the Novacode
i n d e x ,f o rw h i c hw ea r eu n a b l et oo f f e rac l e a r
explanation.
Our findings on evaluating renal TOD confirm those
published by Ratto et al. [5] and Mulè et al. [28], who
documented a negative correlation between AASI and
renal damage as assessed by GFR (r = -0.25, p < 0.01; r
= -0.30, p < 0.01, respectively); and by Hermans et al.
[29], who estimated renal damage based on the MDRD
formula. On evaluating renal damage with urinary albu-
min excretion, we observed no significant results, in
contrast to Leoncini et al. [4], who obtained a positive
association after logarithmic transformation of the albu-
min-creatinine index.
Table 4 Multiple Linear Regression Analysis: Relationship Between TOD and parameters that evaluate arterial stiffness
in hypertensive patients
Variable Not standardized b Confidence interval 95% P Value
Dependent variable: IMT
AASI 0.32 0.12 to 0.52 0.00
Awake-AASI 0.29 0.08 to 0.49 0.01
Sleep-AASI 0.06 -0.01 to 0.13 0.11
AASI-BPVR 0.08 0 01 to 0.15 0.03





AASI 4.95 0.83 to 9.07 0.02
Awake-AASI 4.57 0.42 to 8.72 0.03
Sleep-AASI 2.47 1.10 to 3.84 0.00
AASI-BPVR 1.42 -0.09 to 2.92 0.07
HASI -0.29 -1.54 to 0.96 0.64
HASI-BPVR 0.83 -0.14 to 1.79 0.09
Dependent variable: ABI
AASI -0.28 -0.51 to -0.04 0.02
Awake-AASI -0.28 -0.52 to -0.04 0.02
Sleep-AASI -0.03 -0.11 to 0.05 0.45
AASI-BPVR -0.01 -0.09 to 0.08 0.86
HASI 0.02 -0.05 to 0.09 0.61
HASI-BPVR 0.01 -0.05 to 0.06 0.82
Dependent variable: CKDEPI
AASI -12.74 -44.31 to 18.84 0.43
Awake-AASI -12.55 -44.33 to 19.23 0.44
Sleep-AASI -0.85 -11.42 to 9.72 0.87
AASI-BPVR 2.73 -8.63 to 14.10 0.64
HASI 0.35 -8.94 to 9.63 0.94
HASI-BPVR -7.35 -14.59 to -0.10 0.05
Adjusted Variables: Age; Gender: (male = 1; female = 0); 24 hours Heart rate.
Dependent variables: Carotid IMT: Carotid Intima-media thickness, PWV: pulse wave velocity, ABI: ankle/brachial index and Glomerular filtration.
Independent variable: AASI, Awake-AASI, Sleep-AASI, AASI-BPVR, HASI and HASI-BPVR.
TOD: target organ damage; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; LVMI: Left ventricular mass index; IMT: Intima-media thickness; PWV:
Pulse wave velocity; ABI: Ankle/brachial index; AASI: Ambulatory arterial stiffness index; BPVR: Blood pressure variability ratio; Awake AASI: Ambulatory arterial
stiffness index in Awake time; Sleep AASI: Ambulatory arterial stiffness index in sleep time; HASI: Home arterial stiffness index.
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reported a relationship between AASI and PWV, though
this correlation disappeared upon adjusting for patient
age. In the present study, the association to PWV per-
sisted after fitting for age, gender and heart rate only in
t h ec a s eo fS l e e p - A A S I .T h ep o s i t i v ec o r r e l a t i o no f
AASI to IMT and the negative correlation to ABI like-
wise confirm the results of previous studies [4]. Trianta-
fyllidi et al. [8], in a study of 168 non-treated
hypertensive subjects, obtained a correlation coefficient
between AASI and IMT of r = 0.34, similar to the value
recorded in our series. The association was maintained
i nt h em u l t i p l er e g r e s s i o nm o d e lo n l yi nt h ec a s eo f
those patients exhibiting a dipping pattern.
Study limitations
The main limitation of our study is its cross-sectional
design, which precludes the definition of a causal rela-
tionship between AASI and different parameters in
evaluating TOD. Another limitation is the fact that ours
was not a randomized sample, and so we cannot extra-
polate the results to all hypertensive patients. In order
to correctly interpret the 24-hour, Awake-AASI and
Sleep-AASI values, it must be taken into account that
the waking/sleeping measurements ratio is 3 - as a
result of which the waking values are over-dimensioned
with respect to the sleeping values.
Conclusions
The ambulatory arterial stiffness measures, except HASI
were positively correlated with IMT and PWV, and
negatively correlated with glomerular filtration. After
adjusting for age, gender and 24-hour heart, the vari-
ables that best associated to the variability of IMT,
PWV and ABI were AASI and Awake-AASI, and with
CKDEPI was HASI-BPVR. HASI-BPVR shows greater
correlation with the studied target organ damage para-
meters than HASI.
Figure 1 Boxplots showing the median, 25th and 75th percentiles and maximum and minimum values of AASI and of HASI, according
to the presence or absence of renal, vascular or cardiac target organ damage (TOD). Adjustment for age and gender. Inside the box
mean (CI95%) AASI and HASI adjusted by age and gender.
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Lastly, new prospective studies would be needed in
order to confirm the usefulness of HASI-BPVR in asses-
sing arterial stiffness with home blood pressure
monitoring.
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